Description:Rabbit polyclonal antibody to TGFBR2Immunogen:KLH-conjugated synthetic peptide encompassing a sequence within the center region of human TGFBR2. The exact sequence is proprietary.Purification:The antibody was purified by immunogen affinity chromatography.Clonality:PolyclonalForm:Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.Dilution:WB (1/500 - 1/1000), IH (1/50 - 1/100)Gene Symbol:TGFBR2Alternative Names:TGF-beta receptor type-2; TGFR-2; TGF-beta type II receptor; Transforming growth factor-beta receptor type II; TGF-beta receptor type II; TbetaR-II
Entrez Gene (Human):
7048;
SwissProt (Human):
P37173;
Storage/Stability:Shipped at 4°C. Upon delivery aliquot and store at -20°C for one year. Avoid freeze/thaw cycles.
-
Western blot analysis of TGFBR2 expression in SGC7901 (A), HEK293T (B) whole cell lysates. (Predicted band size: 64 kD; Observed band size: 70; 90 kD)
-
Immunohistochemical analysis of TGFBR2 staining in human brain formalin fixed paraffin embedded tissue section. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0). The section was then incubated with the antibody at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
Impairment of transforming growth factor beta signaling in caveolin-1-deficient hepatocytes: role in liver regeneration
Na,K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis
miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-ß type II receptor
The inhibitory effect of ginsan on TGF-ß mediated fibrotic process
A novel glycosylation signal regulates transforming growth factor beta receptors as evidenced by endo-beta-galactosidase C expression in rodent cells
Human ESC Self-renewal Promoting microRNAs Induce Epithelial-Mesenchymal Transition in Hepatocytes by Controlling the PTEN and TGFß Tumor Suppressor Signaling Pathways
Actively targeted in vivo multiplex detection of intrinsic cancer biomarkers using biocompatible SERS nanotags